NDC 0143-9172-01 - Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9172
- Requested NDC
- 0143-9172-01
- Package NDCs from labels
- 0143-9172-01, 0143-9172-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2025-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2025-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9172-01 | Lidocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 6 | |
| 0143-9172-10 | Lidocaine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0143-9172 | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 5 | Current NDC, 2 package rows | 20250521_5523fdfe-69fd-49a5-b51f-73e2223d49a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9172-01 | ML - Milliliter | 0143-9172 | 7b72ea1e-efec-4df1-95b8-d49d8f018957 | 1 | 2025-06-13 |
| 0143-9172-10 | ML - Milliliter | 0143-9172 | 305cf303-b36f-4e3c-8c47-84127529fe0e | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDRA NEB | SODIUM CHLORIDE | Laboratoire Unither | 30b244c0-84bb-a0a0-e063-6394a90a9dee | 2025-03-19 | Warnings | 451W47IQ8X |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 037764d3-da0e-5ebb-e063-6294a90ab6e0 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| XeroBurn Burn Gel | LIDOCAINE HYDROCHLORIDE | Dynarex Corporation | 58985046-ca9c-12be-e053-2991aa0abe72 | 2025-03-13 | Warnings | V13007Z41A |
| Psora Miasm | EGGSHELL MEMBRANE, WHEY PROTEIN, CALCAREA CARBONICA, LYCOPODIUM CLAVATUM, SULPHUR, ARSENICUM ALBUM, CROTON TIGLIUM, GRAPHITES, HYDROCOTYLE ASIATICA, NATRUM MURIATICUM | Energique, Inc. | 6a12aa49-35fc-41f4-bec8-6f9a20a97caa | 2025-03-13 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Novagenix Labs LLC | 7567ffb5-953a-4be9-9a02-c5a50dcd9306 | 2025-03-12 | Warnings, Adverse reactions | V13007Z41A |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | A2I8C7HI9T |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | ARMAS PHARMACEUTICALS INC. | 2f6e0f3d-ceaf-a853-e063-6394a90a8efb | 2025-03-07 | Warnings, Adverse reactions | V13007Z41A |
| Redicare Burn Gel | REDICARE BURN GEL | Redicare LLC | 947ac362-acfb-3508-e053-2a95a90a2873 | 2025-03-05 | Warnings | V13007Z41A |
| Thera Plus Pain Relief Cleansing | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | Fourstar Group USA, Inc. | 513a620e-f69a-488d-8abc-36e2efccdc13 | 2025-03-04 | Warnings | V13007Z41A |
| 4% lidocaine plus 1% menthol Pain Relief Patch | PAIN RELIEF PATCH, PAIN RELIEF STRIP | Xuzhou Lanting Pharmaceutical Co., Ltd | 2f98ee5e-e4eb-fbda-e063-6394a90a709c | 2025-03-01 | Warnings | V13007Z41A |
| 4% Lidocaine Pain Relief Patch | LIDOCAINE PAIN RELIEF PATCH | Xuzhou Lanting Pharmaceutical Co., Ltd | 2f98a6e9-b7c4-061e-e063-6294a90a6728 | 2025-03-01 | Warnings | V13007Z41A |
| Lightning Products BURN RELIEF | LIDOCAINE HYDROCHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | 555ac696-e761-4a5a-bed8-945dc64d5be5 | 2025-02-27 | Warnings | V13007Z41A |
| Adrenal Liquescence | GLYCYRRHIZA GLABRA, ROSA CANINA, ARALIA QUINQUEFOLIA, GLANDULA SUPRARENALIS (BOVINE), ADRENALINUM, CINCHONA OFFICINALIS, NATRUM MURIATICUM, ZINCUM METALLICUM, ADRENOCORTICOTROPHIN | Nutritional Specialties, Inc. | 5254181b-188e-4ef2-b91e-15e87e31de70 | 2025-02-26 | Warnings | 451W47IQ8X |
| LidoPro Pain Relief | CAPSAICIN AND LIDOCAINE | Preferred Pharmaceuticals Inc. | c259ef92-5d07-4590-adf1-3a106333eee0 | 2025-02-21 | Warnings | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | f1b26274-a55e-4321-b96c-ce0df830f205 | 2025-02-20 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | McKesson Corporation dba SKY Packaging | e1eabd6b-9bb8-646f-e053-2a95a90a7b83 | 2025-02-20 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | NorthStar RxLLC | 6a7fa6c5-b550-46ac-99a3-5c49339e6dbd | 2025-02-19 | Warnings, Adverse reactions | 1010033 1010671 |
| Sunburn Relief Gel | LIDOCAINE HCL | Jell Pharmaceuticals Pvt. Ltd | 2e7c49de-5438-4858-e063-6294a90ad98c | 2025-02-19 | Warnings | V13007Z41A |
| CANNA NUMB Roll On | LIDOCAINE HYDROCHLORIDE, MENTHOL | Cannanumb LLC | c1eb0348-3b0e-4f1c-a46b-1ff4aa165fb4 | 2025-02-17 | Warnings | V13007Z41A |
| NATRUM MURIATICUM 200ck | NATRUM MURIATICUM | SEVENE USA | cf892234-de72-37e1-e053-2995a90a1c39 | 2025-02-11 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.